Transesophageal echocardiography Probe Insertion New Technique

Phase 4

Completed

Conditions: Other heart disorders in diseasesclassified elsewhere,

Registration Number: CTRI/2024/07/071383

Lead Sponsor: U N Mehta Institute of Cardiology and Research Centre

Brief Summary: 1. After careful assessment and written informed consent, patients will be included into study. On arrival, a peripheral venous cannula will be inserted. Standard monitoring include, 5 lead ECG, CVP, pulse oximetry, invasive blood pressure monitoring. General anaesthesia will be induced as per institutional protocol. All patients will be intubated using conventional rigid laryngoscope with appropriately-sized endotracheal tube. After tracheal intubation, oropharyngeal secretions will be suctioned. If there would be blood staining or trauma due to intubation would be diagnosed, patient will be excluded from the study. Patients will be randomised into two groups. Group C (conventional group): TEE probe would be inserted blindly. Group VL (videolaryngoscope group): VL scope would be used for TEE probe insertion. VLScope would be inserted intraorally, and after viewing esophageal inlet, TEE probe would be advanced into esophagus under direct vision. TEE probe will removed after performing cardiac evaluation at the end of surgery and probe tip will be examined for presence or absence of blood. After TEE removal, all patients will be examined for pharyngeal injury, hematoma and sites of injury will be documented. Number of attempts for TEE probe insertion will be documented. Relationship between esophageal inlet and larynx will be documented with a photograph. Number of attempts required for TEE probe insertion and injuries in both the groups will be compared.

Detailed Description: Not available

Recruitment & Eligibility

Status: Completed

Sex: All

Target Recruitment: 100

Inclusion Criteria

Patients of age 2-10 years weight > 5kg.

Exclusion Criteria

Contraindications for TEE insertion Deranged coagulation parameters difficult tracheal intubation patients with sore throat, oropharyngeal infection and sore throat.

Study & Design

Study Type: Interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
To study the incidence of oropharyngeal injury, which is defined as blood at the tip of TEE probe at the end of surgery and/or evidence of injury on VL examination at the end of surgery.	After removal of TEE probe at the time of completion of surgery.

Secondary Outcome Measures

Name	Time	Method
number of attempts required for successful TEE probe insertion & relationship between esophageal inlet & larynx.

Trial Locations

Locations (1): U. N. Mehta Institute of Cardiology and Research Centre
🇮🇳
Ahmadabad, GUJARAT, India
U. N. Mehta Institute of Cardiology and Research Centre
🇮🇳Ahmadabad, GUJARAT, India
Dr Guriqbal Singh
Principal investigator
8238018244
guriqbal6@gmail.com